Real-time enrollment status for this neuromyelitis optica clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05346354 |
| Recruiting Status | Recruiting |
| Condition | Neuromyelitis Optica |
| Phase | Clinical Trial |
| Target Enrollment | 12 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Alexion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of March 2, 2026: Clinical trial NCT05346354 is currently recruiting participants. This clinical trial study for neuromyelitis optica is actively seeking new participants at 6 locations across the United States. The study is sponsored by Alexion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05346354 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05346354 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.